Buxhofer-Ausch, V; Reiter, A; Tomuleasa, C; Woelfler, A; Teichmann, L; Ocroteala, L; Maria-Theresa, K; Charu, C; Schlager, S; Empson, V; Klade, C; Krejcy, K; Gisslinger, H; Koschmieder, S.
Final results from a prospective, multicenter, non-interventional study (BESREMi-PASS) on the safety of ropeginterferon alfa-2b in 229 patients with polycythemia vera
BLOOD. 2025; 146: 2032-2033.
Doi: 10.1182/blood-2025-2032
Web of Science
FullText
FullText_MUG